Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production

Journal of Immunology

Volumn 187, Issue 2, 2011, Pages 676-683

  Clayton, Aled ^a   Al Taei, Saly ^a   Webber, Jason ^a   Mason, Malcolm D ^a   Tabi, Zsuzsanna ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE; ADENOSINE A2 RECEPTOR; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; CD28 ANTIGEN; CD3 ANTIGEN; CD39 ANTIGEN; CYCLIC AMP; INTERLEUKIN 2;

ANTIBODY AFFINITY; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CROSS LINKING; CYTOKINE PRODUCTION; EFFECTOR CELL; ENZYME ACTIVITY; EXOSOME; HUMAN; HUMAN CELL; HYDROLYSIS; MESOTHELIOMA; PLEURA EFFUSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUMOR MICROENVIRONMENT; WESTERN BLOTTING;

5'-NUCLEOTIDASE; ADENOSINE; ADENOSINE MONOPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANTIGENS, CD; APYRASE; CACO-2 CELLS; CELL LINE, TUMOR; DOWN-REGULATION; EXOSOMES; GPI-LINKED PROTEINS; HUMANS; HYDROLYSIS; JURKAT CELLS; MESOTHELIOMA; PHOSPHORYLATION; PLEURAL NEOPLASMS; T-LYMPHOCYTES, REGULATORY;

EID: 79960516623     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003884     Document Type: Article

References (48)

1. Naganuma, M., E. B. Wiznerowicz, C. M. Lappas, J. Linden, M. T. Worthington, and P. B. Ernst. 2006. Cutting edge: critical role for A2A adenosine receptors in the T cell-mediated regulation of colitis. J. Immunol. 177: 2765-2769.
2. Németh, Z. H., D. Bleich, B. Csóka, P. Pacher, J. G. Mabley, L. Himer, E. S. Vizi, E. A. Deitch, C. Szabó, B. N. Cronstein, and G. Haskó. 2007. Adenosine receptor activation ameliorates type 1 diabetes. FASEB J. 21: 2379-2388. (Pubitemid 47230668)
3. Fan, M., and S. Jamal Mustafa. 2006. Role of adenosine in airway inflammation in an allergic mouse model of asthma. Int. Immunopharmacol. 6: 36-45.
4. Csóka, B., Z. H. Németh, P. Rosenberger, H. K. Eltzschig, Z. Spolarics, P. Pacher, Z. Selmeczy, B. Koscsó, L. Himer, E. S. Vizi, et al. 2010. A2B adenosine receptors protect against sepsis-induced mortality by dampening excessive inflammation. J. Immunol. 185: 542-550.
5. Day, Y. J., L. Huang, H. Ye, L. Li, J. Linden, and M. D. Okusa. 2006. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: the role of CD4+ T cells and IFN-gamma. J. Immunol. 176: 3108-3114.
6. Day, Y. J., M. A. Marshall, L. Huang, M. J. McDuffie, M. D. Okusa, and J. Linden. 2004. Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction. Am. J. Physiol. Gastrointest. Liver Physiol. 286: G285-G293.
7. Ohta, A., E. Gorelik, S. J. Prasad, F. Ronchese, D. Lukashev, M. K. Wong, X. Huang, S. Caldwell, K. Liu, P. Smith, et al. 2006. A2A adenosine receptor protects tumors from antitumor T cells. Proc. Natl. Acad. Sci. USA 103: 13132-13137.
8. Hoskin, D. W., J. S. Mader, S. J. Furlong, D. M. Conrad, and J. Blay. 2008. Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review). [Review] Int. J. Oncol. 32: 527-535. (Pubitemid 351330458)
9. Haskó, G., J. Linden, B. Cronstein, and P. Pacher. 2008. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat. Rev. Drug Discov. 7: 759-770.
10. Thorn, J. A., and S. M. Jarvis. 1996. Adenosine transporters. Gen. Pharmacol. 27: 613-620.
11. Havre, P. A., M. Abe, Y. Urasaki, K. Ohnuma, C. Morimoto, and N. H. Dang. 2008. The role of CD26/dipeptidyl peptidase IV in cancer. Front. Biosci. 13: 1634-1645.
12. Deaglio, S., K. M. Dwyer, W. Gao, D. Friedman, A. Usheva, A. Erat, J. F. Chen, K. Enjyoji, J. Linden, M. Oukka, et al. 2007. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204: 1257-1265.
13. Borsellino, G., M. Kleinewietfeld, D. Di Mitri, A. Sternjak, A. Diamantini, R. Giometto, S. Höpner, D. Centonze, G. Bernardi, M. L. Dell'Acqua, et al. 2007. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 110: 1225-1232. (Pubitemid 47281420)
14. Stella, J., L. Bavaresco, E. Braganhol, L. Rockenbach, P. F. Farias, M. R. Wink, A. A. Azambuja, C. H. Barrios, F. B. Morrone, and A. M. Oliveira Battastini. 2010. Differential ectonucleotidase expression in human bladder cancer cell lines. Urol. Oncol. 28: 260-267.
15. Jin, D., J. Fan, L. Wang, L. F. Thompson, A. Liu, B. J. Daniel, T. Shin, T. J. Curiel, and B. Zhang. 2010. CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression. Cancer Res. 70: 2245-2255.
16. Zhi, X., S. Chen, P. Zhou, Z. Shao, L. Wang, Z. Ou, and L. Yin. 2007. RNA interference of ecto-59-nucleotidase (CD73) inhibits human breast cancer cell growth and invasion. Clin. Exp. Metastasis 24: 439-448.
17. Stagg, J., U. Divisekera, N. McLaughlin, J. Sharkey, S. Pommey, D. Denoyer, K. M. Dwyer, and M. J. Smyth. 2010. Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis. Proc. Natl. Acad. Sci. USA 107: 1547-1552.
18. Ohta, A., and M. Sitkovsky. 2001. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414: 916-920. (Pubitemid 34024743)
19. Erdmann, A. A., Z. G. Gao, U. Jung, J. Foley, T. Borenstein, K. A. Jacobson, and D. H. Fowler. 2005. Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo. Blood 105: 4707-4714.
20. Sipka, S., I. Kovács, S. Szántó, G. Szegedi, L. Brugós, G. Bruckner, and A. József Szentmiklósi. 2005. Adenosine inhibits the release of interleukin-1beta in activated human peripheral mononuclear cells. Cytokine 31: 258-263. (Pubitemid 41097361)
21. Lappas, C. M., J. M. Rieger, and J. Linden. 2005. A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells. J. Immunol. 174: 1073-1080. (Pubitemid 40094304)
22. Jeffe, F., K. A. Stegmann, F. Broelsch, M. P. Manns, M. Cornberg, and H. Wedemeyer. 2009. Adenosine and IFN-alpha synergistically increase IFNgamma production of human NK cells. J. Leukoc. Biol. 85: 452-461.
23. Koshiba, M., D. L. Rosin, N. Hayashi, J. Linden, and M. V. Sitkovsky. 1999. Patterns of A2A extracellular adenosine receptor expression in different functional subsets of human peripheral T cells. Flow cytometry studies with anti-A2A receptor monoclonal antibodies. Mol. Pharmacol. 55: 614-624.
24. Zhang, H., D. M. Conrad, J. J. Butler, C. Zhao, J. Blay, and D. W. Hoskin. 2004. Adenosine acts through A2 receptors to inhibit IL-2-induced tyrosine phosphorylation of STAT5 in T lymphocytes: role of cyclic adenosine 3′,5′-monophosphate and phosphatases. J. Immunol. 173: 932-944.
25. Raskovalova, T., A. Lokshin, X. Huang, Y. Su, M. Mandic, H. M. Zarour, E. K. Jackson, and E. Gorelik. 2007. Inhibition of cytokine production and cytotoxic activity of human antimelanoma specific CD8+ and CD4+ T lymphocytes by adenosine-protein kinase A type I signaling. Cancer Res. 67: 5949-5956. (Pubitemid 46985031)
26. Priebe, T., C. D. Platsoucas, and J. A. Nelson. 1990. Adenosine receptors and modulation of natural killer cell activity by purine nucleosides. Cancer Res. 50: 4328-4331.
27. Raskovalova, T., X. Huang, M. Sitkovsky, L. C. Zacharia, E. K. Jackson, and E. Gorelik. 2005. Gs protein-coupled adenosine receptor signaling and lytic function of activated NK cells. J. Immunol. 175: 4383-4391. (Pubitemid 41361973)
28. Zarek, P. E., C. T. Huang, E. R. Lutz, J. Kowalski, M. R. Horton, J. Linden, C. G. Drake, and J. D. Powell. 2008. A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. Blood 111: 251-259.
29. Wilson, J. M., W. G. Ross, O. N. Agbai, R. Frazier, R. A. Figler, J. Rieger, J. Linden, and P. B. Ernst. 2009. The A2B adenosine receptor impairs the maturation and immunogenicity of dendritic cells. J. Immunol. 182: 4616-4623.
30. Welton, J. L., S. Khanna, P. J. Giles, P. Brennan, I. A. Brewis, J. Staffurth, M. D. Mason, and A. Clayton. 2010. Proteomics analysis of bladder cancer exosomes. Mol. Cell. Proteomics 9: 1324-1338.
31. Clayton, A., J. P. Mitchell, J. Court, S. Linnane, M. D. Mason, and Z. Tabi. 2008. Human tumor-derived exosomes down-modulate NKG2D expression. J. Immunol. 180: 7249-7258.
32. Clayton, A., J. P. Mitchell, J. Court, M. D. Mason, and Z. Tabi. 2007. Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2. Cancer Res. 67: 7458-7466. (Pubitemid 47214451)
33. Mitchell, J. P., J. Court, M. D. Mason, Z. Tabi, and A. Clayton. 2008. Increased exosome production from tumour cell cultures using the Integra CELLine Culture System. J. Immunol. Methods 335: 98-105.
34. Andre, F., N. E. Schartz, M. Movassagh, C. Flament, P. Pautier, P. Morice, C. Pomel, C. Lhomme, B. Escudier, T. Le Chevalier, et al. 2002. Malignant effusions and immunogenic tumour-derived exosomes. Lancet 360: 295-305. (Pubitemid 34874721)
35. Lamparski, H. G., A. Metha-Damani, J. Y. Yao, S. Patel, D. H. Hsu, C. Ruegg, and J. B. Le Pecq. 2002. Production and characterization of clinical grade exosomes derived from dendritic cells. J. Immunol. Methods 270: 211-226.
36. Théry, C., A. Clayton, S. Amigorena, and G. Raposo. 2006. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. Protoc. Cell Biol. Chapter 3, Unit 3.22.
37. Raposo, G., H. W. Nijman, W. Stoorvogel, R. Liejendekker, C. V. Harding, C. J. M. Melief, and H. J. Geuze. 1996. B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183: 1161-1172.
38. Reutershan, J., I. Vollmer, S. Stark, R. Wagner, K. C. Ngamsri, and H. K. Eltzschig. 2009. Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs. FASEB J. 23: 473-482.
39. Bard, M. P., J. P. Hegmans, A. Hemmes, T. M. Luider, R. Willemsen, L.-A. A. Severijnen, J. P. van Meerbeeck, S. A. Burgers, H. C. Hoogsteden, and B. N. Lambrecht. 2004. Proteomic analysis of exosomes isolated from human malignant pleural effusions. Am. J. Respir. Cell Mol. Biol. 31: 114-121.
40. Théry, C., M. Ostrowski, and E. Segura. 2009. Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 9: 581-593.
41. Taylor, D. D., and C. Gerçel-Taylor. 2005. Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects. Br. J. Cancer 92: 305-311. (Pubitemid 40343146)
42. Yu, S., C. Liu, K. Su, J. Wang, Y. Liu, L. Zhang, C. Li, Y. Cong, R. Kimberly, W. E. Grizzle, et al. 2007. Tumor exosomes inhibit differentiation of bone marrow dendritic cells. J. Immunol. 178: 6867-6875. (Pubitemid 46847412)
43. Mathivanan, S., and R. J. Simpson. 2009. ExoCarta: a compendium of exosomal proteins and RNA. Proteomics 9: 4997-5000.
44. Blay, J., T. D. White, and D. W. Hoskin. 1997. The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine. Cancer Res. 57: 2602-2605.
45. Mandapathil, M., B. Hilldorfer, M. J. Szczepanski, M. Czystowska, M. Szajnik, J. Ren, S. Lang, E. K. Jackson, E. Gorelik, and T. L. Whiteside. 2010. Generation and accumulation of immunosuppressive adenosine by human CD4 +CD25highFOXP3+ regulatory T cells. J. Biol. Chem. 285: 7176-7186.
46. Kansas, G. S., G. S. Wood, and T. F. Tedder. 1991. Expression, distribution, and biochemistry of human CD39. Role in activation-associated homotypic adhesion of lymphocytes. J. Immunol. 146: 2235-2244.
47. Moncrieffe, H., K. Nistala, Y. Kamhieh, J. Evans, A. Eddaoudi, S. Eaton, and L. R. Wedderburn. 2010. High expression of the ectonucleotidase CD39 on T cells from the inflamed site identifies two distinct populations, one regulatory and one memory T cell population. J. Immunol. 185: 134-143.
48. Thomson, L. F., J. M. Ruedi, A. Glass, G. Moldenhauer, P. Moller, M. G. Low, M. R. Klemens, M. Massaia, and A. H. Lucas. 1990. Production and characterization of monoclonal antibodies to the glycosyl phosphatidylinositol- anchored lymphocyte differentiation antigen ecto-5′-nucleotidase (CD73). Tissue Antigens 35: 9-19.